Gene · 3148
Papers1,965
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,965
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An extramedullary bone model of metastatic dormancy reveals an increased rate of metastatic reactivation upon distant insults. | Cell Rep | 2026 | 42822459 | PubTator, text mining | PubMed |
| An IGF2BP2-MYBL2-HMGB2 Signaling Axis Promotes Macrophage Immune Evasion in Hepatocellular Carcinoma. | Cancer Commun (Lond) | 2026 | 42819712 | PubTator, text mining | PubMed |
| Synergistic antitumor effect of HMGB2 targeting combined with MDM2 inhibitor in diffuse intrinsic pontine glioma therapy. | Front Oncol | 2026 | 42812154 | PubTator, text mining | PubMed |
| Post-transcriptional regulation maintains neurogenic potential of human neural progenitor cells. | Stem Cell Reports | 2026 | 42753731 | PubTator, text mining | PubMed |
| Admission whole-blood transcriptomic characterization of a neutrophil-predominant systemic immune response in patients with acute traumatic brain injury. | Shock | 2026 | 42735045 | PubTator, text mining | PubMed |
| HMGB2 Impacts Cisplatin-Induced DNA Adduct Processing in Chemoresistant Ovarian Cancer Cells. | Genes (Basel) | 2026 | 42650109 | PubTator, text mining | PubMed |
| Extracellular Vesicle miR-558 Regulates Endothelial Function Through HMGB2 in Adult Moyamoya Disease. | Cells | 2026 | 42645183 | PubTator, text mining | PubMed |
| Targeting addiction to HMGB2-driven transcriptional programs in pancreatic cancer. | Cell Rep | 2026 | 42636797 | PubTator, text mining | PubMed |
| KDM6A suppresses proliferation and epithelial-mesenchymal transition in prostate cancer cells. | Urol Oncol | 2026 | 42636791 | PubTator, text mining | PubMed |
| Development and validation of cell-free RNA-based predictive models for preeclampsia using placental single-cell transcriptomic data. | J Reprod Immunol | 2026 | 42623724 | PubTator, text mining | PubMed |
| CircHMGB2 Acts as a Molecular Decoy for IGF2BP1 to Promote Cisplatin Resistance via Grb10/Akt Signaling in Chondrosarcoma. | Acta Orthop Belg | 2026 | 42561431 | PubTator, text mining | PubMed |
| Identifying GADD45A as a Potential R-Loop Regulator in Sepsis Via Machine-Learning and Multi-Omics Analysis. | Shock | 2026 | 42560974 | PubTator, text mining | PubMed |
| Contribution of HMGB1 to keratinocyte inflammation in recessive dystrophic epidermolysis bullosa. | JID Innov | 2026 | 42383160 | PubTator, text mining | PubMed |
| Sensitive Skin Improvement Through Bioinformatics-Identified Cosmetic Ingredients That Regulate Transcriptome-Derived Biomarkers. | Biomolecules | 2026 | 42352310 | PubTator, text mining | PubMed |
| Expression and Survival Analysis Show High Mobility Group (HMG) Family as Prognostic Biomarkers in Breast Cancer. | Eur J Breast Health | 2026 | 42310973 | PubTator, text mining | PubMed |
| Identifying molecular signatures of parapneumonic effusion reveals HMGB2 as the disease progression biomarker. | Respir Res | 2026 | 42277830 | PubTator, text mining | PubMed |
| Tumor-derived HMGB2 induces M2-like macrophage polarization via TRIM65-mediated NLRP3 degradation to promote DLBCL progression. | J Immunother Cancer | 2026 | 42270158 | PubTator, text mining | PubMed |
| Integrative single-cell and spatial transcriptomics analysis reveals a baicalein-responsive 10-gene signature for non-small cell lung cancer. | Transl Oncol | 2026 | 42251782 | PubTator, text mining | PubMed |
| Systematic analysis of programmed cell death-related genes in sepsis reveals immune heterogeneity and enables patient stratification. | Front Cell Dev Biol | 2026 | 42232056 | PubTator, text mining | PubMed |
| Progress in molecular markers associated with radiotherapy efficacy in glioma. | Front Oncol | 2026 | 42125691 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3148/papers